Canadian Cancer Society logo

Hodgkin lymphoma

You are here: 

Treatment of stage IV Hodgkin lymphoma

The following are treatment options for stage IV Hodgkin lymphoma (HL). The types of treatments given are based on the unique needs of the person with cancer.

A CT scan or positron emission tomography (PET) scan may be used during or after chemotherapy to assess how much more treatment is needed. Depending on the results of the scans, more chemotherapy and radiation or just radiation to areas of bulky disease may be given.

Chemotherapy

Chemotherapy is the primary treatment for stage IV HL. Combination chemotherapy is used to treat HL. The types of combination chemotherapy are:

  • ABVD
    • doxorubicin (Adriamycin)
    • bleomycin (Blenoxane)
    • vinblastine (Velbe)
    • dacarbazine (DTIC)
  • Stanford V
    • mechlorethamine (nitrogen mustard, Mustargen)
    • doxorubicin
    • vinblastine
    • vincristine (Oncovin)
    • bleomycin
    • etoposide (Vepesid)
    • prednisone (Deltasone)
  • BEACOPP
    • bleomycin
    • etoposide
    • doxorubicin
    • cyclophosphamide (Cytoxan, Procytox)
    • vincristine
    • procarbazine hydrochloride (Matulane)
    • prednisone
  • MOPP
    • mechlorethamine
    • vincristine
    • procarbazine hydrochloride
    • prednisone

Radiation therapy

External beam radiation therapy may be offered for stage IV HL. It is given after chemotherapy if the HL is localized in an area of the body and can be included in the radiation field.

Clinical trials

People with HL may be offered the opportunity to participate in clinical trials. For more information, go to clinical trials.

Stories

Dr Shana Kelley An ultrasensitive blood test for cancer

Read more

Volunteers provide comfort and kindness

Illustration of volunteers

Thousands of Canadian Cancer Society volunteers work in regional cancer centres, lodges and community hospitals to support people receiving treatment.

Learn more